# A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults

> **NCT02679248** · PHASE2 · TERMINATED · sponsor: **KGK Science Inc.** · enrollment: 67 (actual)

## Conditions studied

- Pre-hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Neo40 Daily®
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02679248
- **Lead sponsor:** KGK Science Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-03
- **Primary completion:** 2017-02-03
- **Final completion:** 2017-03
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2018-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679248, "A Study to Investigate the Effect of a Nitric Oxide Supplementation on Pre- and Mildly Hypertensive Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02679248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*